Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valentina Zipoli

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Expert Review of Neurotherapeutics|October 9, 2009
Cognitive dysfunction in multiple sclerosis: current approaches to clinical managementMaria Pia Amato, Valentina Zipoli
Journal of the Neurological Sciences|April 29, 2006
Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studiesMaria Pia Amato, Valentina Zipoli, Emilio Portaccio
Expert Review of Neurotherapeutics|October 22, 2008
Cognitive changes in multiple sclerosisMaria Pia Amato, Valentina Zipoli, Emilio Portaccio
Journal of the Neurological Sciences|April 29, 2006
Are there protective treatments for cognitive decline in MS?Maria Pia Amato, Emilio Portaccio, Valentina Zipoli
Journal of the Neurological Sciences|May 12, 2009
Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSSEmilio Portaccio, Valentina Zipoli, Benedetta Goretti, et al.
Journal of the Neurological Sciences|September 18, 2007
Intravenous mitoxantrone and cyclophosphamide as second-line therapy in multiple sclerosis: an open-label comparative study of efficacy and safetyValentina Zipoli, Emilio Portaccio, Bahia Hakiki, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 13, 2021
Pegylated interferon beta-1a (Plegridy) Italian real-world experience: a Delphi analysis of injection-site reaction and flu-like symptom managementCinzia Cordioli, Graziella Callari, Roberta Fantozzi, et al.
The Clinical Neuropsychologist|June 1, 2004
Changes in neuropsychological test performance over the workday in multiple sclerosisWilliam W Beatty, Benedetta Goretti, Gianfranco Siracusa, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 23, 2021
Correction to: Pegylated interferon beta-1a (Plegridy) Italian real-world experience: a Delphi analysis of injection-site reaction and flu-like symptom managementCinzia Cordioli, Graziella Callari, Roberta Fantozzi, et al.
Clinical Neurology and Neurosurgery|December 9, 2009
Impact of cognitive impairment on coping strategies in multiple sclerosisBenedetta Goretti, Emilio Portaccio, Valentina Zipoli, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Expert Review of Neurotherapeutics|October 9, 2009
Cognitive dysfunction in multiple sclerosis: current approaches to clinical managementMaria Pia Amato, Valentina Zipoli
Journal of the Neurological Sciences|April 29, 2006
Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studiesMaria Pia Amato, Valentina Zipoli, Emilio Portaccio
Expert Review of Neurotherapeutics|October 22, 2008
Cognitive changes in multiple sclerosisMaria Pia Amato, Valentina Zipoli, Emilio Portaccio
Journal of the Neurological Sciences|April 29, 2006
Are there protective treatments for cognitive decline in MS?Maria Pia Amato, Emilio Portaccio, Valentina Zipoli
Journal of the Neurological Sciences|May 12, 2009
Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSSEmilio Portaccio, Valentina Zipoli, Benedetta Goretti, et al.
Journal of the Neurological Sciences|September 18, 2007
Intravenous mitoxantrone and cyclophosphamide as second-line therapy in multiple sclerosis: an open-label comparative study of efficacy and safetyValentina Zipoli, Emilio Portaccio, Bahia Hakiki, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 13, 2021
Pegylated interferon beta-1a (Plegridy) Italian real-world experience: a Delphi analysis of injection-site reaction and flu-like symptom managementCinzia Cordioli, Graziella Callari, Roberta Fantozzi, et al.
The Clinical Neuropsychologist|June 1, 2004
Changes in neuropsychological test performance over the workday in multiple sclerosisWilliam W Beatty, Benedetta Goretti, Gianfranco Siracusa, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 23, 2021
Correction to: Pegylated interferon beta-1a (Plegridy) Italian real-world experience: a Delphi analysis of injection-site reaction and flu-like symptom managementCinzia Cordioli, Graziella Callari, Roberta Fantozzi, et al.
Clinical Neurology and Neurosurgery|December 9, 2009
Impact of cognitive impairment on coping strategies in multiple sclerosisBenedetta Goretti, Emilio Portaccio, Valentina Zipoli, et al.
Pageof 4